Hydrocodone Bt-Homatropine Mbr (hydrocodone bitartrate/homatropine methylbromide)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Hydrocodone bitartrate is a phenanthrene-derivative opiate agonist antitussive and analgesic agent.
USES: This medication is used to relieve a dry cough usually caused by the common cold or other conditions as prescribed by your doctor. Relieving a cough helps you get more rest and sleep. This product contains 2 medications, hydrocodone and homatropine.
Hydrocodone is an opioid cough suppressant (antitussive) that works on certain centers in the brain to stop the urge to cough. Homatropine belongs to a class of drugs known as anticholinergics. This medication is generally used for short-term treatment.
It should not be used for ongoing coughs from smoking or long-term breathing problems (such as asthma, emphysema), or for coughs with a lot of mucus or fluids (productive coughs), unless directed by your doctor. Opioid cough suppressants should not be used by children younger than 18 years. Children are at higher risk for serious (even fatal) side effects, especially breathing problems.
Talk with the doctor about the risks and benefits of this medication. Cough-and-cold products do not cure colds. Cough due to a common cold often does not need to be treated with medicine.
Ask your doctor or pharmacist about other ways to relieve cough and cold symptoms, such as drinking enough fluids, using a humidifier, or saline nose drops/spray.
Generic name: hydrocodone bitartrate/homatropine methylbromide
Pronunciation: (HYE-droe-KOE-done/hoe-MAT-roe-peen)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Hydrocodone Bt-Homatropine Mbr
Indications
The following indications are listed for Hydrocodone Bt-Homatropine Mbr:
- Cough
Dosing
No dosing information is available for this tab.
Hydrocodone bitartrate and hydrocodone polistirex are administered orally.
When the extended-release oral suspension containing hydrocodone polistirex and chlorpheniramine polistirex (e.g., Tussionex(R) Pennkinetic(R)) is used, patients and caregivers should be strongly advised to use an accurate, calibrated dosing device to measure doses of the suspension. Use of a household teaspoon as a measuring device could result in overdosage. The extended-release oral suspension should not be diluted with other liquids or mixed with other drugs, since this may alter resin binding, thereby altering the rate of hydrocodone absorption and possibly resulting in toxicity. The extended-release oral suspension should not be given more frequently than every 12 hours; if cough is not controlled, the clinician should be contacted. The extended-release oral suspension should be shaken well before each use.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
Concomitant use of opiate agonists and benzodiazepines or other CNS depressants (e.g., anxiolytics, sedatives, hypnotics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opiate agonists, alcohol) may result in profound sedation, respiratory depression, coma, and death. Opiate agonist antitussives should be avoided in patients taking benzodiazepines, other CNS depressants, or alcohol. Concurrent use of anticholinergic agents with hydrocodone may produce paralytic ileus. Concomitant use of opiate agonists with serotonergic drugs can cause serotonin syndrome. (See Drug Interactions in the Opiate Agonists General Statement 28:08.08.)
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
Safe use of hydrocodone during pregnancy has not been established; therefore, the drug should not be administered to pregnant women unless the possible benefits outweigh the potential risks.
It is not known whether hydrocodone is distributed into human milk. A decision should be made to discontinue nursing or the drug, taking into account the importance of the drug to the woman.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.